FindOwnerSearch
Brands and Their Owners
| Brand | Owner (click to sort) | Address | Description |
|---|---|---|---|
| BIOFUNCTIONS | Gene Link, Inc. | 190 Saw Mill River Road Hawthorne NY 10532 | Custom manufacture of oligonucleotides;The mark consists of the wording BioFunctions in plain font appearing to the right of a column of three shaded circles, the lowest of which is the darkest and the uppermost of which is the lightest in shading.;Products to aid researchers in exploring RNA interference, namely, software for automated search and design of siRNAs, synthetic siRNA and custom siRNA;BIO FUNCTIONS;Color is not claimed as a feature of the mark.;Chemicals for use in scientific and medical research preparations, namely, DNA, cDNA, C DNA library, RNA, c DNA fragment, protein expression reagents, chromatography chemicals; RNAi reagents used in life science research and development, not for diagnostic use; Diagnostic reagents for scientific use in the nature of cloning polymerase chain reaction (PCR) products, namely, enzymes being stabilizers and substrates, buffers, nucleotide arrays and primers; small interfering RNA (siRNA) reagents for scientific research purpose; Biochemical kits consisting primarily of random DNA primers, fluorescent dye labeled DNA primers for genetic analysis using fluorescent detection instruments and Oligo d(T) primers; |
| ELSIE BIOTECHNOLOGIES | Elsie Biotechnologies Inc. | 10355 Science Center Drive, Suite 110 San Diego CA 92121 | Custom manufacture of oligonucleotides;Oligonucleotide compounds for use in pharmaceutical therapies; Oligonucleotide delivery agents for use in pharmaceutical therapies; Oligonucleotide-based or -derived pharmaceuticals; Pharmaceuticals comprised of oligonucleotide compounds; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; drug delivery agents consisting of oligonucleotide compounds;Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds; |
| GALXC | Dicerna Pharmaceuticals, Inc. | 75 Hayden Avenue Lexington MA 02421 | custom manufacture of oligonucleotides;Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; Biological compound in the form of a molecular complex that acts as a platform for the delivery of RNA-based drugs to biological cells; and drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies;research and development of anti-cancer drugs and anti-cancer preparations; research and development of pharmaceutical products; |
| GALXC | Dicerna Pharmaceuticals, Inc. | 75 Hayden Avenue Lexington MA 02421 | custom manufacture of oligonucleotides;The mark consists of a stylized version of the term GALXC.;Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; Biological compound in the form of a molecular complex that acts as a platform for the delivery of RNA-based drugs to biological cells; and drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies;Color is not claimed as a feature of the mark.;research and development of anti-cancer drugs and anti-cancer preparations; research and development of pharmaceutical products; |
| GALXC | Dicerna Pharmaceuticals, Inc. | 75 Hayden Avenue Lexington MA 02421 | Custom manufacture of oligonucleotides for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders;Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies;Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; |
|
|
|||
| GALXC | Dicerna Pharmaceuticals, Inc. | 75 Hayden Avenue Lexington MA 02421 | Custom manufacture of oligonucleotides for use in genetic research, pharmaceutical therapies, medical research and treatment of various conditions and disorders;The mark consists of the term GALXC in stylized font with the letter X shown in an enlarged image.;Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies;Color is not claimed as a feature of the mark.;Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; |
| GALXC | Dicerna Pharmaceuticals, Inc. | 75 Hayden Avenue Lexington MA 02421 | Custom manufacture of oligonucleotides;Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; biological compound in the form of a molecular complex that acts as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies; oligonucleotide compounds for use in the targeted delivery of RNAi therapy; oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes;Research and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; |
| GALXC | Dicerna Pharmaceuticals, Inc. | 75 Hayden Avenue Lexington MA 02421 | Custom manufacture of oligonucleotides;The mark consists of a stylized version of the term GALXC.;Biologic preparations for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases and viral infections; biological compound in the form of a molecular complex that acts as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies; oligonucleotide compounds for use in the targeted delivery of RNAi therapy; oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes;Research and development of pharmaceutical products; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, and viral infections; |
| PRISM | Wave Life Sciences Ltd. | Marina One East Tower 7 Straits View #12-00 Singapore 018936 Singapore | Custom manufacture of oligonucleotides for use in genetic research, medical research, pharmaceutical therapies, and the treatment of genetic diseases and disorders;The mark consists of three overlapping triangles appearing to the left of the stylized word PRISM.;Color is not claimed as a feature of the mark.;Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing; |
| PRISM | Wave Life Sciences Ltd. | Marina One East Tower 7 Straits View #12-00 Singapore 018936 Singapore | Custom manufacture of oligonucleotides for use in genetic research, medical research, pharmaceutical therapies, and the treatment of genetic diseases and disorders;Research and development of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; research and development of oligonucleotide compounds for targeted gene silencing; |
| X | Elsie Biotechnologies Inc. | 10355 Science Center Drive, Suite 110 San Diego CA 92121 | Custom manufacture of oligonucleotides;The mark consists of a series of short horizontal lines formed into the shape of an X, superimposed on and largely within a diamond shape with rounded corners.;Oligonucleotide compounds for use in pharmaceutical therapies; Oligonucleotide delivery agents for use in pharmaceutical therapies; Oligonucleotide-based or -derived pharmaceuticals; Pharmaceuticals comprised of oligonucleotide compounds; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; drug delivery agents consisting of oligonucleotide compounds;Color is not claimed as a feature of the mark.;Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds; |
Where the owner name is not linked, that owner no longer owns the brand |
|||